The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon.
To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this link
The USD 4 billion (by 2030) financial opportunity within the microbiome therapeutics (Tx) market and diagnostics (Dx) markets, has been analyzed across the following segments:
The Human Microbiome Market, 2019-2030 report features the following companies, which we identified to be key players in this domain:
Table of Contents
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html
+1 (415) 800 3415
Information! Use the form below to reply to this forum thread or, to reply to an individual post, use the "Quote" button on the relevant post.